Post‐marketing studies of pharmaceutical opioid abuse‐deterrent formulations: a framework for research design and reporting.
Background and aims: Opioid formulations with properties to deter abuse (abuse‐deterrent formulations; ADFs) have been developed as one response to the prescription opioid 'epidemic'. As for all medicines, ADFs undergo evaluation of safety and efficacy prior to registration for marketing. However, r...
| Publicado en: | Addiction Vol. 114; no. 3; pp. 389 - 400 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Mar2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |